SRPK2 and chronic myelogenous leukemia, BCR-ABL1 positive: Across the CML cell line panel, K562 had comparatively high SRPK1 and SRPK2 levels (Supplementary Figure S1D), suggesting that Kasumi-1 and K562 might exhibit differential responses to SRPK1 inhibition by SPHINX.